Health Score

0 Excellent

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 41 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

Medium impact41 DOIs

Add abstracts to 1 article

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Low impact1 DOIs

Deposit reference lists for 1 record

Deposited references power Crossref's Cited-by links between your articles and the literature.

Low impact1 DOIs

DOIs for this ISSN

Showing the top 5 of 144 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Evaluation of Array Comparative genomic Hybridisation in pre… (10.3310/eme04010)	ORCID	37.63	31
2	A randomised, double-blind, placebo-controlled trial of repe… (10.3310/eme03050)	ORCID	35.78	26
3	REmote preconditioning for Protection Against Ischaemia–Repe… (10.3310/eme02030)	ORCID	35.37	25
4	The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive… (10.3310/eme03090)	ORCID	30.76	16
5	Randomised controlled trial of Antiglucocorticoid augmentati… (10.3310/eme02040)	ORCID	26.03	10
6	Effect of Remote Ischaemic preconditioning on Clinical outco… (10.3310/eme03040)	ORCID	26.03	10
7	Imaging perfusion deficits, arterial patency and thrombolysi… (10.3310/eme01010)	ORCID	25.00	9
8	Oral morphine analgesia for preventing pain during invasive… (10.3310/eme06090)	ORCID	25.00	9
9	Alexander technique and Supervised Physiotherapy Exercises i… (10.3310/eme01020)	ORCID	23.86	8
10	Nutritional Evaluation and Optimisation in Neonates (NEON) t… (10.3310/eme03020)	ORCID	23.86	8
11	Wilms’ tumour antigen 1 Immunity via DNA fusion gene vaccina… (10.3310/eme03030)	ORCID	23.86	8
12	Does metformin reduce excess birthweight in offspring of obe… (10.3310/eme03070)	ORCID	23.86	8
13	Randomised controlled trial of ketamine augmentation of elec… (10.3310/eme04020)	ORCID	23.86	8
14	Study of induction of Tolerance to Oral Peanut: a randomised… (10.3310/eme01040)	ORCID	22.58	7
15	A multicentre observational study evaluating image-guided ra… (10.3310/eme01030)	ORCID	21.13	6
16	The REFER (REFer for EchocaRdiogram) study: a prospective va… (10.3310/eme04030)	ORCID	21.13	6
17	Dopamine Augmented Rehabilitation in Stroke (DARS): a multic… (10.3310/eme06050)	ORCID	21.13	6
18	A randomised controlled study of Bronchoscopic Lung Volume R… (10.3310/eme02050)	ORCID	19.45	5
19	An explanatory randomised controlled trial testing the effec… (10.3310/eme02010)	ORCID	17.47	4
20	Efficacy and mode of action of mesalazine in the treatment o… (10.3310/eme02020)	ORCID	17.47	4
21	Next Generation intraoperative Lymph node staging for Strati… (10.3310/eme03060)	ORCID	17.47	4
22	A randomised, double-blind, parallel-group trial to assess m… (10.3310/eme04040)	ORCID	17.47	4
23	The randomised Complete versus Lesion-only PRimary percutane… (10.3310/eme03010)	ORCID	7.53	1
24	A randomised, double-blind, placebo-controlled study to eval… (10.3310/eme03080)	ORCID	7.53	1
25	Effect of a 2-week interruption in methotrexate treatment on… (10.3310/hjty5889)	References	7.53	1
26	Effectiveness, safety and cost-effectiveness of methotrexate… (10.3310/ahdr8524)		0.00	0
27	The impact of pausing Bruton Tyrosine Kinase inhibitor (BTKi… (10.3310/ajed1124)		0.00	0
28	High-sensitivity cardiac troponin I-guided combination angio… (10.3310/aptu2400)		0.00	1
29	Rheumatoid Arthritis Prevention: catalysing PlatfORm Trial d… (10.3310/ashg1864)		0.00	0
30	Treatment guided by fractional exhaled nitric oxide in addit… (10.3310/awoi5587)		0.00	2
31	Autologous stem cell transplantation with low-dose cyclophos… (10.3310/cglt7102)		0.00	1
32	The impact of the Speech Systems Approach on intelligibility… (10.3310/edae1779)		0.00	1
33	Rational treatment selection for primary Merkel Cell Carcino… (10.3310/eewd6684)		0.00	0
34	Parent-determined oral montelukast therapy for preschool whe… (10.3310/eme02060)	ORCID	0.00	0
35	Corrigendum: Nutritional Evaluation and Optimisation in Neon… (10.3310/eme03020-c201706)	ORCID	0.00	0
36	A randomised placebo-controlled trial investigating efficacy… (10.3310/eme03100)	ORCID	0.00	0
37	A randomised placebo-controlled Phase III multicentre trial:… (10.3310/eme04050)		0.00	16
38	Simvastatin to reduce pulmonary dysfunction in patients with… (10.3310/eme05010)		0.00	10
39	Rituximab for the treatment of fatigue in primary biliary ch… (10.3310/eme05020)		0.00	11
40	Functional strength training versus movement performance the… (10.3310/eme05030)		0.00	14
41	Magnetic resonance imaging using ultrasmall superparamagneti… (10.3310/eme05040)		0.00	5
42	Intravitreal aflibercept compared with panretinal photocoagu… (10.3310/eme05050)		0.00	19
43	Levosimendan to prevent acute organ dysfunction in sepsis: t… (10.3310/eme05060)		0.00	6
44	Radically open dialectical behaviour therapy for refractory… (10.3310/eme05070)		0.00	15
45	Sperm selection for assisted reproduction by prior hyalurona… (10.3310/eme06010)		0.00	17
46	Lightmasks that prevent dark adaptation for non-central diab… (10.3310/eme06020)		0.00	2
47	Developing and applying a framework to understand mechanisms… (10.3310/eme06030)		0.00	15
48	Eicosapentaenoic acid and/or aspirin for preventing colorect… (10.3310/eme06040)		0.00	14
49	Telmisartan to reduce insulin resistance in HIV-positive ind… (10.3310/eme06060)		0.00	0
50	Minocycline for negative symptoms of schizophrenia and possi… (10.3310/eme06070)		0.00	3